Birmingham bioscience company awarded multimillion-dollar grant

The grant will support the company's work on its lead program for chronic obstructive pulmonary disease.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.